T-lymphocyte signalling in systemic lupus erythematosus: A lipid raft perspective

Lupus

Volumn 13, Issue 6, 2004, Pages 413-422

  Jury, E C ^a,c   Kabouridis, P S ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CD45; Intracellular signalling; LCK; Lipid rafts; T lymphocytes

Indexed keywords

CD45 ANTIGEN; CD45 TYROSINE PHOSPHATASE; MEMBRANE LIPID; PROTEIN KINASE LCK; PROTEIN TYROSINE PHOSPHATASE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

CELL MEMBRANE; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 3142706505     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu1045rr     Document Type: Review

References (92)

1. Morrow J, Nelson L, Watts R, Isenberg D. Systemic lupus erythematosus. In Morrow J, Nelson L, Watts R, Isenberg D eds. Autoimmune rheumatic disease, second edition. Oxford, UK: Oxford University Press, 1999: 56-103.
2. Dayal AK, Kammer GM. The T cell enigma in lupus. Arthritis Rheum 1996; 39: 23-33.
3. Tsokos GC, Liossis S-NC. Immune cell signalling defects in lupus: activation, anergy and death. Immunol Today 1999; 20: 199-124.
4. Baechler EC, Batliwalla FM, Karypis G et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003; 100: 2610-2615.
5. Bennett L, Palucka AK, Arce E et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711-723.
6. Ohashi PS. T cell signalling and autoimmunity: molecular mechanisms of disease. Nat Rev Immunol 2002; 2: 427-438.
7. Pascual V, Banchereau J, Palucka AK. The central role of dendritic cells and interferon-alpha in SLE. Curr Opin Rheum 2003; 15: 548-556.
8. White S, Rosen A. Apoptosis in systemic lupus erythematosus. Curr Opin Rheum 2003; 15: 557-562.
9. Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001; 19: 225-252.
10. Tsokos GC, Nambiar MP, Tenbrock K, Juang Y-T. Rewiring the T-cell: signalling defects and novel prospects for the treatment of SLE. Trends Immunol 2003; 24: 259-263.
11. Kammer GM, Perl A, Richardson BC, Tsokos GC. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum 2002; 46: 1139-1154.
12. Jury EC, Kabouridis PS, Abba A, Mageed RA, Isenberg DA. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum 2003; 48: 1343-1354.
13. Jury EC, Kabouridis PS, F Flores-Borja, Mageed RA, Isenberg DA. Altered lipid raft-associated signalling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 2004; 113: 1176-1187.
14. Nambiar MP, Enyedy EJ, Fisher CU et al. Abnormal expression of various molecular forms and distruption of T cell receptor ζ chain in patients with systemic lupus erythematosus. Arthritis Rheum 2002; 46: 163-174.
15. Mustelin T, Taskén K. Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem J 2003; 371: 15-27.
16. Davis SJ, Van der Merwe PA. The structure and ligand interactions of CD2: implications for T cell function. Immunol Today 1996; 17: 177-187.
17. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 1998; 92: 83-92.
18. Zhang W, Samelson LE. The role of membrane-associated adaptors in T cell receptor signalling. Cell 2000; 12: 35-41.
19. Simons K, Toomre D. Lipid rafts and signal transduction. Nature Rev 2000; 1: 31-39.
20. Janes PW, Ley SC, Magee AI, Kabouridis PS. The role of lipid rafts in T cell antigen receptor (TCR) signalling. Semin Immunol 2000; 12: 23-34.
21. Singer AL, Koretzky GA. Control of T cell function by positive and negative regulators. Science 2002; 296: 1639-1640.
22. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387: 569-572.
23. Brown DA, London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 1998; 14: 111-136.
24. Dykstra M, Cherukuri A, Sohn HW, Tzeng S-J, Pierce SK. Location is everything: Lipid rafts and immune cell signalling. Annu Rev Immunol 2003; 21: 457-481.
25. Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A. T lymphocyte costimulation mediated by reorganisation of membrane microdomains. Science 1999; 283: 680-682.
26. Tuosto L, Parolini I, Schroder S, Sariacomo M, Lanzavecchia A, Viola A. Organisation of plasma membrane functional rafts upon T cell activation. Eur J Immunol 2001; 31: 345-349.
27. Tomlinson MG, Lin J, Weiss A. Lymphocytes with a complex: adapter proteins in antigen receptor signalling. Immunol Today 2000; 21: 584-591.
28. Brdicka T, Pavlistova D, Leo A et al. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J Exp Med 2000; 191: 1591-1604.
29. Xavier R, Brennan T, Li Q, McCormack C, Seed B. Membrane compartmentation is required for efficient T cell activation. Immunity 1998; 8: 723-732.
30. Giurisato E, McIntosh DP, Tassi M, Gamberucci A, Benedetti A. T cell receptor can be recruited to a subset of plasma membrane rafts, independently of cell signaling and attendantly to raft clustering. J Biol Chem 2003; 278: 6771-6778.
31. Freiberg BA, Kupfer H, Maslanik JD, Kappler J, Zaller DM, Kupfer A. Staging and resetting T cell activation in SMACs. Nature Immunol 2002; 3: 911-917.
32. lck associated with glycolipid-enriched membrane domains. J Cell Biol 1996; 135: 1515-1523.
33. Burack WR, Lee KH, Holdorf AD, Dustin ML, Shaw AS. Quantitative imaging of raft accumulation in the immunological synapse. J Immunol 2002; 169: 2837-2841.
34. Acuto O, Cantrell D. T cell activation and the cytoskeleton. Annu Rev Immunol 2000; 18: 165-184.
35. Rodgers W and Zavzavadjian J. Glycolipid-enriched membrane domains are assembled into membrane patches by associating with the actin cytoskeleton. Exp Cell Res 2001; 267: 173-183.
36. Jordan S, Rodgers W. T cell glycolipid-enriched membrane domains are constitutively assembled as membrane patches that translocate to immune synapses. J Immunol 2003; 171: 78-87.
37. Martin M, Schneider H, Azouz A, Rudd CE. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J Exp Med 2001; 194: 1675-1681.
38. Vratsanos GS, Jung S, Park YM, Craft J. CD4(+) T cells from lupusprone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: a model to explain spontaneous T cell activation in lupus. J Exp Med 2001; 193: 329-337.
39. Schade AE, Levine AD. Lipid raft heterogeneity in human peripheral blood T lymphoblasts: A mechanism for regulating the initiation of TCR signal transduction. J Immunol 2002; 168: 2233-2239.
40. Drevot P, Langlet C, Guo XJ et al. TCR signal initiation machinery is pre-assembled and activated in a subset of membrane rafts. EMBO J 2002; 21: 1899-1908.
41. Pike LJ. Lipid rafts: heterogeneity on the high seas. Biochem J 2004; 378: 281-292.
42. Gomez-Mouton C, Abad JL, Mira E et al. Segregation of leading edge and uropod components into specific lipid rafts during T cell polarization. Proc Natl Acad Sci USA 2001; 98: 9642-9647.
43. Kammer GM. Impaired T cell capping and receptor regeneration in active systemic lupus erythematosus: evidence for a disorder intrinsic to the T lymphocyte. J Clin Invest 1983; 72: 1686-1697.
44. Matache C, Stefanescu M, Onu A et al. Tyrosine phosphorylation in peripheral lymphocytes from patients with systemic lupus erythematosus. Autoimmunity 1996; 24: 217-228.
45. Matache C, Stefanescu M, Onu A et al. P56lck activity and expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus. Autoimmunity 1999; 29: 111-120.
46. Blasini AM, Alonzo E, Chacon R, Riera R, Stekman IL, Rodriguez MA. Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T lymphocytes from patients with systemic lupus erythematosus. Lupus 1998; 7: 515-523.
47. Blasini AM, Brundula V, Paris M et al. Protein tyrosine kinase activity in T lymphocytes from patients with systemic lupus erythematosus. J Autoimmunity 1998; 11: 387-393.
48. Molina TJ, Kishihara K, Siderovski DP et al. Profound block in thymocyte development in mice lacking p56lck. Nature 1992; 357: 161-164.
49. Kabouridis PS, Magee AI, Ley SC. S-acylation of LCK protein tyrosine kinase is essential for its signalling function in T lymphocytes. EMBO J 1997; 16: 4983-4998.
50. Straus D, Weiss A. Genetic evidence for the involvement of the lck tryrosine kinase in signal transduction through the T cell antigen receptor. Cell 1992; 70: 585-593.
51. Ardouin L, Boyer C, Gillet A et al. Crippling of CD3-ζ ITAMs does not impair T cell receptor signalling. Immunity 1999; 10: 409-420.
52. Enyedy EJ, Nambiar MP, Liossis S-NC, Dennis G, Kammer GM, Tsokos GC. Fcε receptor type 1 γ chain in T cells of patients with systemic lupus erythematosus. Arthritis Rheum 2001; 44: 1114-1121.
53. Holdorf AD, Green JM, Levin SD et al. Proline residues in CD28 and Src homology (SH)3 domain of Lck are required for T cell costimulation. J Exp Med 1999; 190: 375-384.
54. Acuto O, Michel F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nature Rev Immunol 2003; 3: 939-951.
55. Seddon B, Legname G, Tomlinson P, Zamoyska R. Long-term survival but impaired homeoststic proliferation of naive T cells in the absence of p56lck. Science 2000; 290: 127-131.
56. 2+ moblization and CD28 costimulation in mature primary T cells. Eur J Immunol 2001; 31: 3567-3579.
57. Nervi S, Atlan-Gepner C, Kahn-Perles B et al. Specific deficiency of p56lck expression in T lymphocytes from type I diabetic patients. J Immunol 2000; 165: 5874-5883.
58. Romagnoli P, Strahan D, Pelosi M, Cantagrel A, van Meerwijk JPM. A potential role for protein tyrosine kinase p56lck in rheumatoid arthritis synovial fluid T lymphocyte hyporesponsiveness. Int Immunol 2001; 13: 305-312.
59. Horwitz DA, Stohl W, Gray JD. T lymphocytes, natural killer cells and immune regulation. In Wallace DJ, Hann BH eds. Dubois lupus erythematosus, sixth edition. Philadelphia, USA: Lippincott, Williams and Wilkins, 2002: 157-185.
60. Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nature Immunol 2002; 3: 20-26.
61. Hermiston ML, Xu Z, Majeti R, Weiss A. Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases. J Clin Invest 2002; 109: 9-14.
62. Penninger JM, Irie-Sasaki J, Sasaki T, Oliveira-dos-Santos AJ. CD45: new jobs for an old acquaintance. Nature Immunol 2001: 2: 389-396.
63. Rao N, Miyake S, Reddi AL et al. Negative regulation of Lck by Cbl ubiquitin ligase. Proc Natl Acad Sci USA 2002; 99: 3794-3799.
64. Hawash IY, Kesavan KP, Magee AI, Geahlen RL, Harrison ML. The Lck SH3 domain negatively regulates localisation to lipid rafts through an interation with c-Cbl. J Biol Chem 2002; 277: 5683-5691.
65. Leitenberg D, Balamuth F, Bottomly K. Changes in the T cell receptor macromolecular signalling complex and membrane microdomains during T cell development and activation. Semin Immunol 2001; 13: 129-138.
66. Williams JC, Wierenga RK, Saraste M. Insights into Src kinase functions - structural comparisons. Trends Biochem Sci 1998; 23: 179-184.
67. Furukawa T, Itoh M, Krueger NX, Streuli M, Saito H. Specific interaction of the CD45-protein tyrosine phosphorylated CD3 ζ chain. Proc Natl Acad Sci USA 1994; 25: 942-946.
68. Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signalling thresholds in immune cells. Annu Rev Immunol 2003; 21: 107-137.
69. Janes PW, Ley SC, Magee AI. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J Cell Biol 1999; 174: 447-461.
70. Edmonds SD, Ostergaard HL. Dynamic association of CD45 with detergent-insoluble microdomains in T lymphocytes. J Immunol 2002; 169: 5036-5042.
71. Irles C, Symons A, Michel F, Bakker TR, van der Merwe PA, Acuto O. CD45 ectodomain controls interaction with GEMs and Lck activity for optimal TCR signaling. Nat Immunol 2003; 4: 189-197.
72. Vassilopoulos D, Kovacs B, Tsokos GC. TCR/CD3 complex-mediated signal transduction pathway in T cell lines from patients with systemic lupus erythematosus. J Immunol 1995; 155: 2269-2281.
73. Dar O, Salamam MR, Seifert MH, Isenberg DA. Spontaneous antibody secreting cells against DNA and common environmental antigens in systemic lupus erythematosus. J Autoimmunity 1990; 3: 523-530.
74. Takeuchi T, Pang M, Amano J, Koide J, Abe T. Reduced protein tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1997; 109: 20-26.
75. Xu Z, Weiss A. Negative regulation of CD45 by differential homodimerisation of the alternatively spliced isoforms. Nature Immunol 2002; 3: 764-771.
76. Majeti R, Xu Z, Parslow TG et al. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 2000; 103: 1059-1070.
77. lck tyrosine kinase in T cell antigen receptor signal transduction. J Biol Chem 2002; 277: 1912-1918.
78. Ishii T, Ohnuma K, Murakami A et al. CD26-mediated signalling for T cell activation occurs in lipid rafts through its association with CD45RO. PNAS 2001; 98: 12138-12143.
79. Salgado FJ, Lojo J, Alonso-Lebrero JL et al. A role for IL-12 in the regulation of T cell plasma membrane compartmentation. J Biol Chem 2003; 278: 24849-24857.
80. Kammer GM, Khan IU, Malemud CJ. Deficient type I protein kinase A isoenzyme activity in systemic lupus erythematosus T lymphocytes. J Clin Invest 1994; 94: 422-430.
81. Torgersen KM, Vang T, Abrahamsen H et al. Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src kinase (CSK) from lipid rafts. J Biol Chem 2001; 276: 29313-29318.
82. Aandahl EM, Moretto WJ, Haslett PA et al. Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. J Immunol 2002; 169: 802-808.
83. Vang T, Sundvold V, Levy FO et al. Activation of the COOH-terminal Src kinase (CSK) by cAMP-dependent protein kinase inhibits signalling through the T cell receptor. J Exp Med 2001; 193: 497-507.
84. Krawczyk C, Penninger JM. Molecular controls of antigen receptor clustering and autoimmunity. Trends Cell Biol 2001; 11: 212-220.
85. Liu Y-C, Gu H. Cbl and Cbl-b in T-cell regulation. Trends Immunol 2002; 23: 140-143.
86. Murphy MA, Schnall RG, Venter DJ et al. Tissue hyperplasia and enhanced T cell signalling via ZAP-70 in c-Cbl deficient mice. Mol Cell Biol 1998; 18: 4872-4882.
87. Naramura M, Kole HK, Hu RJ, Gu H. Altered thymic positive selection and intracellular signals in cbl-deficient mice. PNAS 1998; 95: 15547-15552.
88. Rudd CE, Schneider H. Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nature Rev Immunol 2003; 3: 544-556.
89. Krawczyk C, Bachmaier K, Sasaki T et al. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity 2000; 13: 463-473.
90. Yi Y, McNerney M, Datta SK. Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells. J Immunol 2000; 165: 6627-6634.
91. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001; 294: 1540-1543.
92. Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979; 301: 5-8.